Admission Date:  [**2178-12-13**]       Discharge Date:  [**2179-1-11**]  Date of Birth:   [**2142-1-9**]       Sex:  F   CHIEF COMPLAINT:  Abdominal pain  HISTORY OF PRESENT ILLNESS:  This is a 36 year old female with a history of adult polycystic disease status post peritoneal dialysis who presented with sudden onset of severe epigastric pain with bilious emesis.
Liver shows fullness of the pancreas with fluid stranding anterior to the pancreas.
PAST MEDICAL HISTORY:  Hypertension, VRE infection, anemia of chronic disease, cardiac tamponade (transudate, cx neg) seizure, questionable history of peritoneal endometriosis, cervical dysplasia, in situ, Clostridium difficile colitis, status post bilateral nephrectomy.
Clonidine .3 b.i.d.
Labetalol 400 b.i.d.
Dilantin 400 b.i.d.
Lactulose 30 5.
Lipitor 20 7.
Prednisone 10 mg q.d.
RenaGel 800  ALLERGIES:  Penicillin, FK-506.
Peritonitis - The patient was treated with intraperitoneal Vancomycin and initially gentamicin.
Subsequently gentamicin was discontinued.
The patient completed a 14 day course of Vancomycin which was uncomplicated.
The patient was placed NPO and given intravenous fluids.
The patient was started on Dilaudid for pain control.
After this trial the patient was placed NPO for the remainder of her hospital course of two weeks.
Gastroenterology was following the patient closely and believed that a conservative management was most appropriate.
The plan was conservative management with pain medication, NPO and fluids as necessary.
Gastroenterology suggested a trial of Actigall 300 mg p.o.
Neurological - The patient has a history of seizures and was on Dilantin prior to admission.
The patient was coded and had a seizure and subsequently became unresponsive.
The patient was intubated and put on pressors and transferred to the Medicine Intensive Care Unit.
Shortly after transfer to the Medicine Intensive Care Unit the patient was weaned off pressors and blood pressure was subsequently stable.
Over the four week course of the hospitalization the patient's Dilantin was decreased until the end of the hospitalization the patient was on Dilantin 100 mg t.i.d.
Renal - The patient has a history of adult polycystic kidney disease, status post cadaveric renal transplant with chronic rejection.
The patient returned to hemodialysis in [**2178-5-19**] and was started on peritoneal dialysis in [**2178-10-19**].
When the patient was on peritoneal dialysis prior to the renal transplant the patient had multiple episodes of peritonitis.
The patient was treated with Clonidine patch.
On discharged the patient was on .5 mg per day of Clonidine patch.
The patient tolerated the total parenteral nutrition well, however, her BUN continued to increase while she was on total parenteral nutrition.
Nutrition suggested changing to French chain aminoacid total parenteral nutrition, however, the renal team felt that this was expensive and an unproven therapy, therefore recommended against changing to French chain aminoacids for the purpose of lowering the BUN.
Clonidine patch .5 mg per 24 hour period q. week 2.
Dilantin 100 mg p.o.
Prednisone 5 mg p.o.
Actigall 300 mg p.o.
Dilaudid 2 mg prn 6.
Duragesic patch 100 mcg q.
72 hours prn 7.
Triamcinolone cream  DISCHARGE STATUS:  The patient left Against-Medical-Advice.
